Jack Nathan Medical Corp.
JNHMF
$0.0036
-$0.0001-2.70%
OTC PK
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -10.37% | 5.69% | 14.98% | 24.65% | -283.32% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -10.37% | 5.69% | 14.98% | 24.65% | -283.32% |
| Cost of Revenue | -18.99% | -18.75% | -7.58% | 38.34% | -281.27% |
| Gross Profit | -7.62% | 13.34% | 23.12% | 21.34% | -283.99% |
| SG&A Expenses | -37.63% | 16.48% | 35.71% | 40.51% | -204.07% |
| Depreciation & Amortization | -23.75% | 50.61% | -11.61% | 11.24% | -305.88% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -32.30% | 10.63% | 23.19% | 38.40% | -224.85% |
| Operating Income | 363.18% | -37.09% | -60.66% | -118.42% | 121.48% |
| Income Before Tax | 62.56% | 13.04% | -47.18% | -145.27% | 163.35% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 22.13% | 13.04% | -47.18% | -142.78% | 188.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 678.05% | 13.04% | -47.18% | -142.78% | 33.48% |
| EBIT | 363.18% | -37.09% | -60.66% | -118.42% | 121.48% |
| EBITDA | 212.22% | -29.82% | -92.83% | -165.99% | 136.39% |
| EPS Basic | 671.94% | 14.69% | -43.38% | -136.23% | 34.23% |
| Normalized Basic EPS | 218.33% | -23.68% | -106.78% | -139.53% | 148.39% |
| EPS Diluted | 666.84% | 14.69% | -30.00% | -120.27% | 34.23% |
| Normalized Diluted EPS | 269.23% | -19.44% | -114.04% | -116.28% | 141.94% |
| Average Basic Shares Outstanding | 1.83% | 1.88% | 2.79% | 3.31% | 0.26% |
| Average Diluted Shares Outstanding | 2.22% | 7.39% | -1.08% | 13.98% | 0.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |